Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jonathan Poole files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark C. Schneyer - $1.13M in ACAD purchases and sales in the last 12 months
- James M. Daly - $671K in ACAD purchases and sales in the last 12 months
- James Kihara - $603K in ACAD purchases and sales in the last 12 months
- Elizabeth H.Z. Thompson - $506K in ACAD purchases and sales in the last 12 months
- Adams Catherine Owen - $250K in ACAD purchases and sales in the last 12 months
- Jennifer J. Rhodes - $245K in ACAD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jonathan Poole?
Jonathan Poole is a corporate insider of ACADIA PHARMACEUTICALS INC (ACAD). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jonathan Poole last file a Form 4?
The most recent primary Form 4 on record is dated 1 June 2026, one of 2 filings going back to 2026.